Paxon

This page contains information on Paxon for veterinary use.
The information provided typically includes the following:

Paxon Indications
Warnings and cautions for Paxon
Direction and dosage information for Paxon

Paxon

This treatment applies to the following species:

Dogs

Company: Vetoquinol USA

● Supplement for the support of urinary tract health

● FOR DOGS

CHEWABLE TABLETS

Product Facts

ACTIVE INGREDIENTS PER TABLET (815 MILLIGRAMS):

Purified Cranberry Fruit Extract (Vaccinium macrocarpon)

100 mg

Inactive Ingredients

Artificial Beef Flavoring (FlavorPAL^®), Cellulose, Croscarmellose Sodium, Fumed Silica, Lecithin, Magnesium Stearate, Silicon Dioxide, Sorbitol.

CAUTIONS:

If animal’s condition worsens or does not improve, stop product administration and consult your veterinarian. Safe use in pregnant animals or animals intended for breeding has not been proven.

For use in dogs only.

Paxon™ is a supplement used to support normal urinary tract health in dogs.

Directions For Use

Administer to dogs once a day from 4 to 6 weeks, or as recommended by veterinarian.

<10 lb	1/2 tablet
10 lb - 25 lb	1 tablet
26 lb - 40 lb	1 1/2 tablets
41 lb - 55 lb	2 tablets
56 lb - 70 lb	2 1/2 tablets
71 lb - 100 lb	3 tablets

Warnings

Not for human consumption. Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately.

Manufactured by:

ADH Health Products, Inc., 215 North Route 303, Congers, NY 10920 USA

QUESTIONS?

Distributed by:

Vetoquinol USA, Inc., Ft. Worth, TX (USA) 76137

1 (800) 267-5707

www.vetoquinolusa.com

Net Contents:
30 Tablets (24.45 g)	425855 7 V2022-08

CPN: 1005098.4

VETOQUINOL USA, INC.
4250 N. SYLVANIA AVENUE, FORT WORTH, TX, 76137

Customer Service:		800-267-5707
Website:		www.vetoquinolusa.com
Email:		info@vetoquinolusa.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.